
IQV · NYSE
IQVIA Holdings Inc.
$279.36 +1.13 (+0.41%)
Company overview
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers cloud-based applications, real-world evidence solutions, and strategic consulting services. The Research & Development Solutions segment provides project management, clinical monitoring, clinical trial support, virtual trials, and laboratory services including central laboratory, genomic, bioanalytical, and biomarker services. The Contract Sales & Medical Solutions segment offers healthcare provider and patient engagement services and medical affairs support.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Exchange
- NYSE
- Market cap
- $46B
- Employees
- 89,000
- Headquarters
- Durham, NC
- Website
- iqvia.com
- CEO
- Ari Bousbib
- Listed
- May 9, 2013
- P/E
- 34.32
- Dividend yield
- 0.00%
Company financials
- Revenue
- $16.6B
- Gross profit
- $4.3B
- Operating income
- $2.3B
- EBITDA
- $3.5B
- Net income
- $1.4B
- EPS
- $8.14
- Total assets
- $29.7B
- Total debt
- $2.1B
- Gross margin
- 26.11%
- Net margin
- 8.33%
- Earnings yield
- 2.91%
Showing FY 2025